Back to News
Market Impact: 0.25
Proteome Sciences Reports Higher H1 2026 Revenue, Narrower Loss; Stock Down
Source: Nasdaq
Corporate EarningsCompany FundamentalsHealthcare & Biotech
Proteome Sciences reported higher revenue and a narrower net loss for the six months ended June 30, 2026. The interim results indicate improving operating performance for the contract research organization, though no specific revenue or loss figures were provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
PRM0.55
More News
- Companies promised AI gains— here's how the payoff showed up in earnings
- FBI blames North Korea for record $6.3bn crypto heist
- Binance to resume crypto withdrawals in phases after record $6 billion hack
- AWS grows 39% and Amazon will spend even more on AI in 2027
- SpaceX loses bid to toss NAACP lawsuit over Memphis data center air pollution
- U.S workers just took home their smallest share of capital since at least 1947—and the lowest ever recorded